APA (7th ed.) Citation

Kontopoulou, K., Nakas, C. T., Ainatzoglou, A., Ifantidou, A., Ntotsi, P., Katsioulis, C., & Papazisis, G. (2021). Immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in elderly people over 85 years of age in Greece: The GREVAXIMO study. Aging clinical and experimental research, 33(12), 3385-3389. https://doi.org/10.1007/s40520-021-01997-7

Chicago Style (17th ed.) Citation

Kontopoulou, Konstantina, Christos Theodore Nakas, Alexandra Ainatzoglou, Athina Ifantidou, Paschalina Ntotsi, Christos Katsioulis, and Georgios Papazisis. "Immunogenicity of the BNT162b2 MRNA Covid-19 Vaccine in Elderly People over 85 years of Age in Greece: The GREVAXIMO Study." Aging Clinical and Experimental Research 33, no. 12 (2021): 3385-3389. https://doi.org/10.1007/s40520-021-01997-7.

MLA (9th ed.) Citation

Kontopoulou, Konstantina, et al. "Immunogenicity of the BNT162b2 MRNA Covid-19 Vaccine in Elderly People over 85 years of Age in Greece: The GREVAXIMO Study." Aging Clinical and Experimental Research, vol. 33, no. 12, 2021, pp. 3385-3389, https://doi.org/10.1007/s40520-021-01997-7.